A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas.

about

A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas.

Item

http://www.wikidata.org/entity/Q47992039

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A pediatric brain tumor consor ...... use intrinsic pontine gliomas.

@en

A pediatric brain tumor consor ...... use intrinsic pontine gliomas.

@nl

type

Item

label

A pediatric brain tumor consor ...... use intrinsic pontine gliomas.

@en

A pediatric brain tumor consor ...... use intrinsic pontine gliomas.

@nl

prefLabel

A pediatric brain tumor consor ...... use intrinsic pontine gliomas.

@en

A pediatric brain tumor consor ...... use intrinsic pontine gliomas.

@nl

P1476

A pediatric brain tumor consor ...... use intrinsic pontine gliomas.

@en

P2093

Alberto Broniscer

http://www.w3.org/2001/XMLSchema#string

Annabelle Lemenuel-Diot

http://www.w3.org/2001/XMLSchema#string

Arnold C Paulino

http://www.w3.org/2001/XMLSchema#string

Christine Lopez-Diaz

http://www.w3.org/2001/XMLSchema#string

Christine McIntyre

http://www.w3.org/2001/XMLSchema#string

Eugene I Hwang

http://www.w3.org/2001/XMLSchema#string

Jack M Su

http://www.w3.org/2001/XMLSchema#string

James M Boyett

http://www.w3.org/2001/XMLSchema#string

Larry Kun

http://www.w3.org/2001/XMLSchema#string

Patricia Baxter

http://www.w3.org/2001/XMLSchema#string

P2860

K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas

Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas

A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.

Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98).

A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study.

Rationally designed pharmacogenomic treatment using concurrent capecitabine and radiotherapy for glioblastoma; gene expression profiles associated with outcome.

Clinical pharmacokinetics of capecitabine.

Children's Oncology Group's 2013 blueprint for research: central nervous system tumors.

MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC).

Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group.

P31

scholarly article

P356

10.1002/PBC.26832

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29090526

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

diffuse intrinsic pontine glioma

phase II clinical trial

P932

5774861

http://www.w3.org/2001/XMLSchema#string